메뉴 건너뛰기




Volumn 74, Issue 2, 2013, Pages 476-481

The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients

Author keywords

Low molecular weight heparin; Lower extremity deep venous thrombosis; Pulmonary embolism

Indexed keywords

ENOXAPARIN;

EID: 84875278702     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31827c5f66     Document Type: Article
Times cited : (18)

References (28)
  • 1
    • 0001101632 scopus 로고
    • Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients
    • Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients. Br J Surg. 1961; 48:475-489.
    • (1961) Br J Surg. , vol.48 , pp. 475-489
    • Sevitt, S.1    Gallagher, N.2
  • 2
    • 0028018944 scopus 로고
    • A prospective study of venous thromboembolism after major trauma
    • Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331: 1601-1606.
    • (1994) N Engl J Med. , vol.331 , pp. 1601-1606
    • Geerts, W.H.1    Code, K.I.2    Jay, R.M.3    Chen, E.4    Szalai, J.P.5
  • 4
    • 77958480479 scopus 로고    scopus 로고
    • Isolated calf vein thrombosis should be treated with anticoagulation
    • Lohr JM, Fellner AN. Isolated calf vein thrombosis should be treated with anticoagulation. Dis Mon. 2010;56:590-600.
    • (2010) Dis Mon. , vol.56 , pp. 590-600
    • Lohr, J.M.1    Fellner, A.N.2
  • 6
    • 0032717329 scopus 로고    scopus 로고
    • High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism
    • Girard P, Musset D, Parent F, Maitre S, Phlippoteau C, Simonneau G. High prevalence of detectable deep venous thrombosis in patients with acute pulmonary embolism. Chest. 1999;116:903-908.
    • (1999) Chest. , vol.116 , pp. 903-908
    • Girard, P.1    Musset, D.2    Parent, F.3    Maitre, S.4    Phlippoteau, C.5    Simonneau, G.6
  • 7
    • 0029799559 scopus 로고    scopus 로고
    • A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma
    • Geerts WH, Jay RM, Code KI, et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med. 1996;335:701-707.
    • (1996) N Engl J Med. , vol.335 , pp. 701-707
    • Geerts, W.H.1    Jay, R.M.2    Code, K.I.3
  • 8
    • 0031729410 scopus 로고    scopus 로고
    • Prevention of venous thromboembolism
    • Clagett GP, Anderson FA Jr, Geerts W, et al. Prevention of venous thromboembolism. Chest. 1998;114(suppl 5):531S-560S.
    • (1998) Chest. , vol.114 , Issue.SUPPL. 5
    • Clagett, G.P.1    Anderson Jr., F.A.2    Geerts, W.3
  • 9
    • 0036632825 scopus 로고    scopus 로고
    • Practice management guidelines for the prevention of venous thromboembolism in trauma patients: The EAST practice management guidelines work group
    • Rogers FB, Cipolle MD, Velmahos G, Rozycki G, Luchette FA. Practice management guidelines for the prevention of venous thromboembolism in trauma patients: the EAST practice management guidelines work group. J Trauma. 2002;53:142-164.
    • (2002) J Trauma. , vol.53 , pp. 142-164
    • Rogers, F.B.1    Cipolle, M.D.2    Velmahos, G.3    Rozycki, G.4    Luchette, F.A.5
  • 10
    • 67749084293 scopus 로고    scopus 로고
    • Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients
    • Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma. 2009;66: 1509-1517.
    • (2009) J Trauma. , vol.66 , pp. 1509-1517
    • Van Py Cho, S.D.1    Underwood, S.J.2    Morris, M.S.3    Watters, J.M.4    Schreiber, M.A.5
  • 11
    • 77951082865 scopus 로고    scopus 로고
    • Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients
    • Malinoski D, Jafari F, Ewing T, et al. Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma. 2010;68:874-880.
    • (2010) J Trauma. , vol.68 , pp. 874-880
    • Malinoski, D.1    Jafari, F.2    Ewing, T.3
  • 12
    • 4344623920 scopus 로고    scopus 로고
    • Throm-boembolism after trauma: An analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank
    • Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Throm-boembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240: 490-498.
    • (2004) Ann Surg. , vol.240 , pp. 490-498
    • Knudson, M.M.1    Ikossi, D.G.2    Khaw, L.3    Morabito, D.4    Speetzen, L.S.5
  • 13
    • 0025283737 scopus 로고
    • Pulmonary embolism in major trauma patients
    • O'Malley KF, Ross SE. Pulmonary embolism in major trauma patients. J Trauma. 1990;30:748-750.
    • (1990) J Trauma. , vol.30 , pp. 748-750
    • O'Malley, K.F.1    Ross, S.E.2
  • 14
    • 80053289938 scopus 로고    scopus 로고
    • Three thousand seven hundred thirty-eight posttraumatic pulmonary emboli: A new look at an old disease
    • Knudson MM, GomezD, Haas B, Cohen MJ, Nathens AB. Three thousand seven hundred thirty-eight posttraumatic pulmonary emboli: a new look at an old disease. Ann Surg. 2011;254:625-632.
    • (2011) Ann Surg. , vol.254 , pp. 625-632
    • Knudson, M.M.1    Gomezd Haas, B.2    Cohen, M.J.3    Nathens, A.B.4
  • 15
    • 0019422886 scopus 로고
    • Is embolic risk conditioned by location of deep venous thrombosis?
    • Moser KM, LeMoine Jr. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med. 1981;94(4 pt 1):439-444.
    • (1981) Ann Intern Med. , vol.94 , Issue.4 PART 1 , pp. 439-444
    • Moser, K.M.1    Lemoine, J.R.2
  • 16
  • 17
    • 58649114725 scopus 로고    scopus 로고
    • Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: Preliminary report
    • Yamaki T, Nozaki M, Sakurai H, Takeuchi M, Soejima K, Kono T. Presence of lower limb deep vein thrombosis and prognosis in patients with symptomatic pulmonary embolism: preliminary report. Eur J Vasc Endovasc Surg. 2009;37:225-231.
    • (2009) Eur J Vasc Endovasc Surg. , vol.37 , pp. 225-231
    • Yamaki, T.1    Nozaki, M.2    Sakurai, H.3    Takeuchi, M.4    Soejima, K.5    Kono, T.6
  • 18
    • 0028228894 scopus 로고
    • Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enox-aparin Clinical Trial Group
    • Spiro TE, Johnson GJ, Christie MJ, et al. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Enox-aparin Clinical Trial Group. Ann Intern Med. 1994;121:81-89.
    • (1994) Ann Intern Med. , vol.121 , pp. 81-89
    • Spiro, T.E.1    Johnson, G.J.2    Christie, M.J.3
  • 19
    • 16544369276 scopus 로고    scopus 로고
    • Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury
    • Hebbeler SL, Marciniak CM, Crandall S, Chen D, Nussbaum S, Mende-lewski S. Daily vs twice daily enoxaparin in the prevention of venous thromboembolic disorders during rehabilitation following acute spinal cord injury. J Spinal Cord Med. 2004;27:236-240.
    • (2004) J Spinal Cord Med. , vol.27 , pp. 236-240
    • Hebbeler, S.L.1    Marciniak, C.M.2    Crandall, S.3    Chen, D.4    Nussbaum, S.5    Mende-Lewski, S.6
  • 20
    • 79953883522 scopus 로고    scopus 로고
    • Review of a large clinical series: Once-versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients
    • Bush S, Leclaire A, Hampp C, Lottenberg L. Review of a large clinical series: once-versus twice-daily enoxaparin for venous thromboembolism prophylaxis in high-risk trauma patients. J Intensive Care Med. 2011;26: 111-115.
    • (2011) J Intensive Care Med. , vol.26 , pp. 111-115
    • Bush, S.1    Leclaire, A.2    Hampp, C.3    Lottenberg, L.4
  • 21
    • 84859910803 scopus 로고    scopus 로고
    • Oregon Health & Science University Trauma Research Group. Incidence of deep vein thrombosis is increased with 30 mg twice daily dosing of enoxaparin compared with 40 mg daily
    • Riha GM, Van PY, Differding JA, Schreiber MA, Oregon Health & Science University Trauma Research Group. Incidence of deep vein thrombosis is increased with 30 mg twice daily dosing of enoxaparin compared with 40 mg daily. Am J Surg. 2012;203:598-602.
    • (2012) Am J Surg. , vol.203 , pp. 598-602
    • Riha, G.M.1    Van, P.Y.2    Differding, J.A.3    Schreiber, M.A.4
  • 22
    • 11144356709 scopus 로고    scopus 로고
    • Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients
    • discussion 731-733
    • Schultz DJ, Brasel KJ, Washington L, et al. Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma. 2004;56:727-731; discussion 731-733.
    • (2004) J Trauma. , vol.56 , pp. 727-731
    • Schultz, D.J.1    Brasel, K.J.2    Washington, L.3
  • 23
    • 67649185621 scopus 로고    scopus 로고
    • Four years of an aggressive prophylaxis and screening protocol for venous thromboembolismina large trauma population
    • Adams RC, Hamrick M, Berenguer C, Senkowski C, Ochsner MG. Four years of an aggressive prophylaxis and screening protocol for venous thromboembolismina large trauma population. J Trauma. 2008;65:300-308.
    • (2008) J Trauma. , vol.65 , pp. 300-308
    • Adams, R.C.1    Hamrick, M.2    Berenguer, C.3    Senkowski, C.4    Ochsner, M.G.5
  • 24
    • 0037986374 scopus 로고    scopus 로고
    • Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
    • Priglinger U, Delle Karth G, Geppert A, et al. Prophylactic anticoagulation with enoxaparin: is the subcutaneous route appropriate in the critically ill? Crit Care Med. 2003;31:1405-1409.
    • (2003) Crit Care Med. , vol.31 , pp. 1405-1409
    • Priglinger, U.1    Delle Karth, G.2    Geppert, A.3
  • 25
    • 0036474480 scopus 로고    scopus 로고
    • Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin
    • Mayr AJ, Dunser M, Jochberger S, et al. Antifactor Xa activity in intensive care patients receiving thromboembolic prophylaxis with standard doses of enoxaparin. Thromb Res. 2002;105:201-204.
    • (2002) Thromb Res. , vol.105 , pp. 201-204
    • Mayr, A.J.1    Dunser, M.2    Jochberger, S.3
  • 26
    • 33644848865 scopus 로고    scopus 로고
    • Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight
    • Al Dieri R, Alban S, Beguin S, Hemker HC. Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight. J Thromb Haemost. 2006;4:83-89.
    • (2006) J Thromb Haemost. , vol.4 , pp. 83-89
    • Al Dieri, R.1    Alban, S.2    Beguin, S.3    Hemker, H.C.4
  • 27
    • 0036090770 scopus 로고    scopus 로고
    • Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: Association with recurrence and new thrombosis
    • Piovella F, Crippa L, Barone M, et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis. Hae-matologica. 2002;87:515-522.
    • (2002) Hae-matologica. , vol.87 , pp. 515-522
    • Piovella, F.1    Crippa, L.2    Barone, M.3
  • 28
    • 79251484670 scopus 로고    scopus 로고
    • The post thrombotic syndrome
    • Kahn SR. The post thrombotic syndrome. Thromb Res. 2011;127(suppl 3): S89-S92.
    • (2011) Thromb Res. , vol.127 , Issue.SUPPL. 3
    • Kahn, S.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.